ABCL Insider Trading
Insider Ownership Percentage: 28.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
AbCellera Biologics Insider Trading History Chart
This chart shows the insider buying and selling history at AbCellera Biologics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
AbCellera Biologics Share Price & Price History
Current Price: $2.22
Price Change: ▲ Price Increase of +0.13 (6.22%)
As of 04/2/2025 05:00 PM ET
AbCellera Biologics Insider Trading History
AbCellera Biologics Institutional Trading History
Data available starting January 2016
AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
Read More on AbCellera Biologics
Volume
4,065,564 shs
Average Volume
2,442,812 shs
Market Capitalization
$661.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.45
Who are the company insiders with the largest holdings of AbCellera Biologics?